Ir al contenido principal

Episodio 6. Dolor complejo y colchicina post hoc

Imagen
By Dr Juan Gulin

Episodio 6. Dolor complejo y colchicina post hoc

En este episodio revisamos una actualizacion Cochrane de intervenciones en el sindrome de dolor regional complejo y un estudio post hoc de colchicina para el tratamiento de osteoartrosis. No te lo pierdas!

https://pod.link/1688456486/episode/78a19ac36ea18179dbefbdaf85e5e027 

Ferraro MC, Cashin AG, Wand BM, Smart KM, Berryman C, Marston L, Moseley GL, McAuley JH, O'Connell NE. Interventions for treating pain and disability in adults with complex regional pain syndrome‐ an overview of systematic reviews. Cochrane Database of Systematic Reviews 2023, Issue 6. Art. No.: CD009416. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009416.pub3/full

Herramienta AMSTAR de evaluacion de RS https://amstar.ca/index.php 

Herramienta GRADE para evaluacion de publicaciones en salud https://www.gradeworkinggroup.org/

Association of Low-Dose Colchicine With Incidence of Knee and Hip Replacement.Exploratory Analyses From a Randomized, Controlled, Double-Blind Trial

https://www.acpjournals.org/doi/10.7326/M23-0289

Entradas populares de este blog

Episodio 8. Simulando tofacitinib versus adalimumab. Datos de vida real potenciados.

By Dr Juan Gulin
 Episodio 8. Simulando tofacitinib versus adalimumab. Datos de vida real potenciados. La base de datos OPAL de Australia es una verdadera joya. Comentamos un "ensayo clinico simulado" utilizando los pacientes con AR y sus HCEs comparando tofacitinib versus adalimumab y comparamos con recomendaciones EULAR y datos de un ECA de 2017. Deakin CT , De Stavola BL , Littlejohn G, et al. Comparative Effectiveness of Adalimumab vs Tofacitinib in Patients With Rheumatoid Arthritis in Australia. JAMA Netw Open. 2023;6(6):e2320851. doi:10.1001/jamanetworkopen.2023.20851 https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2806589 Littlejohn  GO, Tymms  KE, Smith  T, Griffiths  HT.  Using big data from real-world Australian rheumatology encounters to enhance clinical care and research.   Clin Exp Rheumatol . 2020;38(5):874-880. https://pubmed.ncbi.nlm.nih.gov/31820719/  Fleischmann  R, Mysler ...
Read more »

Episodio 19: Primer sintoma de espondilitis

By Dr Juan Gulin
Episodio 19: Primer sintoma de espondilitis Investigadores españoles y mexicanos examinan las cohortes RESPONGISER y RESPONDIA en pos de establecer los primeros sintomas y signos de las distintas espondiloartropatias Puche-Larrubia MÁ, Ladehesa-Pineda L, Vázquez-Mellado J, et al. Identification of the first signs or symptoms in different spondyloarthritis subtypes and their association with HLA-B27: data from REGISPONSER and RESPONDIA registries. RMD Open 2023;9:e003235. doi: 10.1136/ rmdopen-2023-003235 E. Collantes, P. Zarco, E. Muñoz, X. Juanola, J. Mulero, J. L. Fernández-Sueiro, J. C. Torre-Alonso, J. Gratacós, C. González, E. Batlle, P. Fernández, L. F. Linares, E. Brito, L. Carmona, Disease pattern of spondyloarthropathies in Spain: description of the first national registry (REGISPONSER)—extended report, Rheumatology , Volume 46, Issue 8, August 2007, Pages 1309–1315, https://doi.org/10.1093/rheumatology/kem084   Janitzia Vázquez-Mellado a , P...
Read more »

Episodio 5. Guias y vagos

By Dr Juan Gulin
 Episodio 5. Guias y vagos.  https://pod.link/1688456486 OP0234 2023 UPDATE OF EULAR RECOMMENDATIONS FOR THE TREATMENT OF SYSTEMIC SCLEROSIS. https://ard.bmj.com/content/82/Suppl_1/154   Research Update: Using Vagus Nerve Stimulation for Rheumatic Disease. April 8, 2023 • By Mary Beth Nierengarten . https://www.the-rheumatologist.org/article/research-update-using-vagus-nerve-stimulation-for-rheumatic-disease/ ClinicalTrials.gov is a database of privately and publicly funded clinical studies conducted around the world. https://clinicaltrials.gov/
Read more »